Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 455 results found. Search for [ sputnik v vaccine in india ]

Results 20 to 40 of 455
Shailendra Shukla
New Delhi, June 5, 2021
'Publicity': Delhi HC junks Juhi Chawla's suit against 5G; imposes Rs 20-lakh fineThe Delhi High Court on Friday dismissed the lawsuit by actress Juhi Chawla against the implementation of 5G network technology in the country. The court ruled the plea was filed to gain \"publicity\" and that the plaintiffs, Chawla and two others, have abused the process of law. The Delhi High Court has imposed a fine of Rs 20 lakh on the plaintiffs. After the court pronounced the judgement, Chawla's counsel s...


PTI
June 5, 2021
While the firms will continue to make these three vaccines, this action will allow US-based companies that supply these vaccine manufacturers to make their own decisions on which orders to fulfil first


BusinessToday.In
June 4, 2021
There are many colleges and universities in US that are asking students to be revaccinated if they have received vaccines -- like Sputnik V and Covaxin -- that have not received WHO approval.  They are citing a lack of data on efficacy and safety of these vaccines


BusinessToday.In
New Delhi, June 4, 2021
India will receive COVID vaccines from the United States and this news was communicated to PM Modi by US Vice President Kamala Harris in her first phone call to him. The Biden-Harris administration's framework looks to share at least 80 million vaccines globally by the end of June. This will be a part of the US strategy on global vaccine sharing. Vice President Harris has been calling Heads of States and communicating the Global Allocation Plan for the first 25 million doses. PM Modi tweeted after the call, appreciating the US for its assurance of vaccine supplies. Watch the video for more.Also Read: DCGI approves Serum's request to manufacture Sputnik V COVID-19 vaccine in India


BusinessToday.In
New Delhi, June 4, 2021
A study by the central government on the devastating second COVID wave has revealed that despite Delhiites having sero positivity of over 56 per cent, they got little protection against the Delta variant that took over the national capital March 2021 onwards. The study was conducted by scientists of INSACOG (the consortium of labs undertaking genome sequencing in India) and National Centre for Disease Control (NCDC). The rise in prevalence of the Delta variant was accompanied by a corresponding rise in the overall positivity rate. Watch the video for more on this variant.Also Read: DCGI approves Serum's request to manufacture Sputnik V COVID-19 vaccine in India


BusinessToday.In
June 4, 2021
Due non-availability of normal commercial flight operations a number of foreign nationals who came to India prior to March 2020 on valid Indian visas have remained stranded in India


BusinessToday.In
June 4, 2021
Pune-based SII has partnered with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, in Russia for developing Sputnik V COVID-19 vaccine in India at its licensed facility in Hadapsar


Reuters
June 3, 2021
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world's second-most populous country reels from a devastating second wave of infections


BusinessToday.In
New Delhi, June 3, 2021
Pune-based Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday. Russia's RDIF sovereign wealth fund, which is marketing Sputnik V globally, has already signed agreements with six leading Indian manufacturers including Dr Reddy's Laboratories, Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma and Virchow Biotech. The vaccine is currently being manufactured in India by Dr Reddy's Laboratories. The SII has also sought approval for test analysis and examination. Once permitted, the company will need to conduct clinical trials. Watch the video for more.Also Read: Serum Institute seeks nod for licence to manufacture Sputnik V in India


BusinessToday.In
June 3, 2021
Once the company gets permission, it will have to conduct clinical trials and if successful, the Serum Institute will become the seventh company to manufacture Sputnik V


BusinessToday.In
June 3, 2021
Snowman Logistics stock touched an intraday high of Rs 59, rising 14.9% against previous close of Rs 51.35 on BSE


PTI
June 2, 2021
Seeking to scrutinise the COVID vaccination policy in detail, the top court also asked the Centre to provide information including as to how Rs 35,000 crore, earmarked for vaccines, has been spent so far, and to place on record all relevant documents and file notings reflecting its thinking culminating in the policy


PB Jayakumar
June 2, 2021
DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of origin


PTI
June 1, 2021
A GMR Hyderabad Air Cargo (GHAC) press release said the vaccine consignment arrived from Russia on a specially chartered freighter RU-9450 which touched down at Hyderabad Airport at 03.43 hours


BusinessToday.In
May 31, 2021
According to Chairman of COVID-19 working group under National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora, work is expected to begin 'in a few weeks'


PTI
May 30, 2021
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working round the clock in spite of various challenges because of the pandemic.


PTI
May 29, 2021
The health ministry said the Centre is regularly interacting with national and international manufacturers like Pfizer, Moderna to make vaccines available in the country


Reuters
May 27, 2021
India has been inoculating its people with the AstraZeneca vaccine produced locally at the Serum Institute, Covaxin made by local firm Bharat Biotech, and has begun rolling out Russia's Sputnik V


BusinessToday.In
May 27, 2021
Pfizer told Indian authorities that its vaccine has demonstrated \"high effectiveness\" against the COVID-19 variant prevalent in India and on people of Indian ethnicity or nationality


Nidhi Singal
May 27, 2021
Samsung says LDS syringes will minimise the amount of drug left in the syringes after an injection, reducing vaccine wastage, and enable 20 per cent more people to get the dose with the same amount of vaccine


PAGES 2 OF 23  12345